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Atopic dermatitis 
The articles in this issue of CME reflect the views of 
a number of individuals who developed the guideline 
for the management of atopic dermatitis (AD) to 
improve the outcome of its treatment in South Africa 
(SA). AD has a major impact on the quality of life 
of sufferers and it is hoped that the articles and the guidelines they 
embody, if implemented, play a role in achieving these outcomes. 
Not only is AD the most common skin disease in children, but it 
causes tremendous morbidity. Engaging with many of these suffering 
children and their parents daily, is emotionally draining and energy 
sapping. No other skin condition places such demands on resources, 
time and the human spirit. 
It is therefore essential that the management of AD should 
be optimal, with a thorough understanding of the pathogenesis, 
approaching it in a multi-professional manner. Understanding 
the disease will also contribute towards eliminating unnecessary 
investigations, unnecessary and inappropriate interventions and 
unsubstantiated treatment modalities. The simplistic way of 
approaching AD as ‘an allergy’ is long outdated, as the complexity of 
the condition becomes increasingly apparent with the publication of 
new information. All healthcare workers involved in the management 
of AD should take note of these guiding principles and try to 
implement them in clinical practice whenever possible. 
The basis of each topic was developed through general consensus by 
a panel of four dermatologists and five paediatricians (including three 
allergists) from SA, based on evidence from an extensive literature review. 
Draft documents were made available for comment via the internet. All 
input, where appropriate, was then incorporated into the guideline.
This issue of CME consists of six full-length articles, covering the 
following topics: aetiopathogenesis,[1] epidemiology,[2] diagnosis,[3] 
patient education and specialist referral,[4] non-pharmacological 
treatment[5] and pharmacological treatment.[6] Summaries of the 
general approach to and guideline for the management of AD are 
also provided (available online only).[7]
A disclaimer has to be added: these guidelines do not represent all 
possible methods of management applicable to all patients, do not 
exclude any other reasonable methods, and will not ensure successful 
treatment in every situation. The responsible physician should 
take the unique circumstances of each patient into consideration 
regarding decisions about a specific therapy. 
The pharmaceutical companies Astellas Pharma and Galderma 
generously co-sponsored the meeting of the work group and all costs 
generated by the meeting. 
We trust that all who read this issue will find it stimulating, 
informative and helpful in daily practice to improve the condition of 
these suffering children and adults. 
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